Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Tiede

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Hamostaseologie|April 16, 2021
Consensus Recommendations for Intramuscular COVID-19 Vaccination in Patients with HemophiliaChristian Pfrepper, Katharina Holstein, Christoph Königs, et al.
Annals of Hematology|February 27, 2016
Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH)Iris Appelmann, Stephan Kreher, Stefani Parmentier, et al.
Research and Practice in Thrombosis and Haemostasis|October 18, 2024
Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI studyChristian Herbert Burgmann, Ulrich J Sachs, Karolin Trautmann-Grill, et al.
Therapeutic Advances in Hematology|April 8, 2022
International consensus recommendations on the management of people with haemophilia BDaniel P Hart, Davide Matino, Jan Astermark, et al.
Journal of Thrombosis and Haemostasis : JTH|June 27, 2024
Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia AChristina Hart, Robert Klamroth, Ulrich J Sachs, et al.
Xenotransplantation|December 16, 2011
Transgenic expression of human heme oxygenase-1 in pigs confers resistance against xenograft rejection during ex vivo perfusion of porcine kidneysBjörn Petersen, Wolf Ramackers, Andrea Lucas-Hahn, et al.
Blood Advances|August 12, 2025
Sustained Survival Benefit of Emicizumab and Postponed Immunosuppression in Acquired Hemophilia AInga M Schimansky, Christiane Dobbelstein, Robert Klamroth, et al.
Artificial Organs|September 17, 2022
Microembolic signal monitoring in patients with HeartMate 3 and HeartWare left ventricular assist devices: Association with antithrombotic treatment and cerebrovascular eventsKim Kristin Ravenberg, Maria Magdalena Gabriel, Andrei Leotescu, et al.
Blood|December 18, 2014
Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humansChristoph J Hofbauer, Shawn F J Whelan, Maria Hirschler, et al.
Haematologica|November 13, 2025
Thrombin generation to predict breakthrough bleeding in patients with acquired hemophilia A under emicizumab prophylaxisFabius J Pelzer, Ella I Ertekin, Olga Oleshko, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Hamostaseologie|April 16, 2021
Consensus Recommendations for Intramuscular COVID-19 Vaccination in Patients with HemophiliaChristian Pfrepper, Katharina Holstein, Christoph Königs, et al.
Annals of Hematology|February 27, 2016
Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH)Iris Appelmann, Stephan Kreher, Stefani Parmentier, et al.
Research and Practice in Thrombosis and Haemostasis|October 18, 2024
Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI studyChristian Herbert Burgmann, Ulrich J Sachs, Karolin Trautmann-Grill, et al.
Therapeutic Advances in Hematology|April 8, 2022
International consensus recommendations on the management of people with haemophilia BDaniel P Hart, Davide Matino, Jan Astermark, et al.
Journal of Thrombosis and Haemostasis : JTH|June 27, 2024
Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia AChristina Hart, Robert Klamroth, Ulrich J Sachs, et al.
Xenotransplantation|December 16, 2011
Transgenic expression of human heme oxygenase-1 in pigs confers resistance against xenograft rejection during ex vivo perfusion of porcine kidneysBjörn Petersen, Wolf Ramackers, Andrea Lucas-Hahn, et al.
Blood Advances|August 12, 2025
Sustained Survival Benefit of Emicizumab and Postponed Immunosuppression in Acquired Hemophilia AInga M Schimansky, Christiane Dobbelstein, Robert Klamroth, et al.
Artificial Organs|September 17, 2022
Microembolic signal monitoring in patients with HeartMate 3 and HeartWare left ventricular assist devices: Association with antithrombotic treatment and cerebrovascular eventsKim Kristin Ravenberg, Maria Magdalena Gabriel, Andrei Leotescu, et al.
Blood|December 18, 2014
Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humansChristoph J Hofbauer, Shawn F J Whelan, Maria Hirschler, et al.
Haematologica|November 13, 2025
Thrombin generation to predict breakthrough bleeding in patients with acquired hemophilia A under emicizumab prophylaxisFabius J Pelzer, Ella I Ertekin, Olga Oleshko, et al.
Pageof 13